Detection and validation of copy number variation in X-linked mental retardation

Cytogenetic and Genome Research

Volumn 123, Issue 1-4, 2009, Pages 44-53

  Bauters, M ^a   Weuts, A ^a   Vandewalle, J ^a   Nevelsteen, J ^a   Marynen, P ^a   Van Esch, H ^b   Froyen, G ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOME; CHROMOSOME DUPLICATION; COGNITIVE DEFECT; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENETIC VARIABILITY; HUMAN; IDIOPATHIC DISEASE; MENTAL DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; VALIDATION PROCESS; X CHROMOSOME; X CHROMOSOME INACTIVATION; X LINKED MENTAL RETARDATION;

ANIMALS; CHROMOSOME DELETION; GENE DOSAGE; HUMANS; MENTAL RETARDATION, X-LINKED; MODELS, GENETIC; SELECTION (GENETICS); X CHROMOSOME;

EID: 62549112650     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184691     Document Type: Review

References (100)

1. Adams MD, Sekelsky JJ: From sequence to phenotype: reverse genetics in Drosophila melanogaster. Nat Rev Genet 3:189-198 (2002).
2. Bakker CE, Verheij C, Willemsen R, Vanderhelm R, Oerlemans F, et al: Fmr1 knockout mice - a model to study fragile-X mental-retardation. Cell 78:23-33 (1994).
3. Bauters M, Van Esch H, Marynen P, Froyen G: X chromosome array-CGH for the identification of novel X-linked mental retardation genes. Eur J Med Genet 48:263-275 (2005).
4. Bauters M, Van EH, Friez MJ, Boespflug-Tanguy O, Zenker M, et al: Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair. Genome Res 18:847-858 (2008).
5. Bhat SS, Schmidt KR, Ladd S, Kim KC, Schwartz CE, et al: Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenet Genome Res 112:170-175 (2006).
6. Billuart P, Winter CG, Maresh A, Zhao X, Luo L: Regulating axon branch stability: the role of p190 RhoGAP in repressing a retraction signaling pathway. Cell 107:195-207 (2001).
7. Bonnet C, Gregoire MJ, Brochet K, Raffo E, Leheup B, Jonveaux P: Pure de-novo 5 Mb duplication at Xp11.22-p11.23 in a male: phenotypic and molecular characterization. J Hum Genet 51:815-821 (2006).
8. Brand AH, Perrimon N: Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118:401-415 (1993).
9. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O: Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93:067-9072 (1996).
10. Carrel L, Willard HF: X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400-404 (2005).
11. Chao HT, Zoghbi HY, Rosenmund C: MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56:58-65 (2007).
12. Chen L, Toth M: Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050 (2001).
13. Chen RZ, Akbarian S, Tudor M, Jaenisch R: Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-331 (2001).
14. Chiurazzi P, Schwartz CE, Gecz J, Neri G: XLMR genes: update 2007. Eur J Hum Genet 16:422-434 (2008).
15. Chocholska S, Rossier E, Barbi G, Kehrer-Sawatzki H: Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. Am J Med Genet A 140:604-610 (2006).
16. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, et al: Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679-2689 (2004).
17. Crawley JN: Behavioral phenotyping strategies for mutant mice. Neuron 57:809-818 (2008).
18. D'Adamo P, Menegon A, Lo NC, Grasso M, Gulisano M, et al: Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 19:134-139 (1998).
19. D'Adamo P, Welzl H, Papadimitriou S, Raffaele DB, Tiveron C, et al: Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice. Hum Mol Genet 11:2567-2580 (2002).
20. de Brouwer AP, Yntema HG, Kleefstra T, Lugtenberg D, Oudakker AR, et al: Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum Mutat 28:207-208 (2007).
21. de Vries BB, Winter R, Schinzel A, van Ravenswaaij-Arts C: Telomeres: a diagnosis at the end of the chromosomes. J Med Genet 40:385-398 (2003).
22. de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, et al: Diagnostic genome profiling in mental retardation. Am J Hum Genet 77:606-616 (2005).
23. del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, et al: Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 8:784-792 (2006).
24. Dockendorff TC, Su HS, McBride SM, Yang Z, Choi CH, et al: Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34:73-984 (2002).
25. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, et al: Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat 28:1124-1132 (2007).
26. Friedman JM, Baross A, Delaney AD, Ally A, Arbour L, et al: Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 79:500-513 (2006).
27. Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, et al: Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118:e1687-e1695 (2006).
28. Froyen G, Bauters M, Boyle J, Van Esch H, Govaerts K, et al: Loss of SLC38A5 and FTSJ1 at Xp11.23 in three brothers with non-syndromic mental retardation due to a microdeletion in an unstable genomic region. Hum Genet 121:539-547 (2007a).
29. Froyen G, Van Esch H, Bauters M, Hollanders K, Frints SG, et al: Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum Mutat 28:1034-1042 (2007b).
30. Froyen G, Corbett M, Vandewalle J, Jarvela I, Lawrence O, et al: Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet 82:432-443 (2008).
31. Fukami M, Kirsch S, Schiller S, Richter A, Benes V, et al: A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation. Am J Hum Genet 67:563-573 (2000).
32. Gecz J: The molecular basis of intellectual disability: novel genes with naturally occurring mutations causing altered gene expression in the brain. Front Biosci 9:1-7 (2004).
33. Giraldo P, Montoliu L: Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 10:83-103 (2001).
34. Govek EE, Newey SE, Akerman CJ, Cross JR, Van der Veken L, Van Aelst L: The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat Neurosci 7:364-372 (2004).
35. Guy J, Hendrich B, Holmes M, Martin JE, Bird A: A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326 (2001).
36. Hardwick SA, Reuter K, Williamson SL, Vasudevan V, Donald J, et al: Delineation of large deletions of the MECP2 gene in Rett syndrome patients, including a familial case with a male proband. Eur J Hum Genet 15:1218-1229 (2007).
37. Hayashi ML, Choi SY, Rao BSS, Jung HY, Lee HK, et al: Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice. Neuron 42:773-787 (2004).
38. Hayashi S, Honda S, Minaguchi M, Makita Y, Okamoto N, et al: Construction of a high-density and high-resolution human chromosome X array for comparative genomic hybridization analysis. J Hum Genet 52:397-405 (2007).
39. Heaney JD, Bronson SK: Artificial chromosome-based transgenes in the study of genome function. Mamm Genome 17:791-807 (2006).
40. Hing H, Xiao J, Harden N, Lim L, Zipursky SL: Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97:853-863 (1999).
41. Honda S, Hayashi S, Kato M, Niida Y, Hayasaka K, et al: Clinical and molecular cytogenetic characterization of two patients with non-mutational aberrations of the FMR2 gene. Am J Med Genet A 143:687-693 (2007).
42. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al: Detection of large-scale variation in the human genome. Nat Genet 36:49-951 (2004).
43. Inlow JK, Restifo LL: Molecular and comparative genetics of mental retardation. Genetics 166:835-881 (2004).
44. Jehee FS, Rosenberg C, Krepischi-Santos AC, Kok F, Knijnenburg J, et al: An Xq22.3 duplication detected by comparative genomic hybridization microarray (Array-CGH) defines a new locus (FGS5) for FG syndrome. Am J Med Genet A 139:221-226 (2005).
45. Jensen LR, Lenzner S, Moser B, Freude K, Tzschach A, et al: X-linked mental retardation: a comprehensive molecular screen of 47 candidate genes from a 7.4 Mb interval in Xp11. Eur J Hum Genet 15:68-75 (2007).
46. Jugloff DG, Jung BP, Purushotham D, Logan R, Eubanks JH: Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. Neurobiol Dis 19:18-27 (2005).
47. Jun L, Frints SGM, Duhamel H, Herold A, Abad-Rodrigues J, et al: NXF5, a novel member of the nuclear RNA export factor family, is lost in a male patient with a syndromic form of mental retardation. Curr Biol 11:1381-1391 (2001).
48. Kaech S, Banker G: Culturing hippocampal neurons. Nat Protoc 1:2406-2415 (2006).
49. Khelfaoui M, Denis C, van Galen E, de Bock F, Schmitt A, et al: Loss of X-linked mental retardation gene oligophrenin 1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J Neurosci 27:439-9450 (2007).
50. Koolen DA, Nillesen WM, Versteeg MH, Merkx GF, Knoers NV, et al: Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 41:892-899 (2004).
51. Kousoulidou L, Parkel S, Zilina O, Palta P, Puusepp H, et al: Screening of 20 patients with X-linked mental retardation using chromosome X-specific array-MAPH. Eur J Med Genet 50:399-410 (2007).
52. Laumonnier F, Cuthbert PC, Grant SG: The role of neuronal complexes in human X-linked brain diseases. Am J Hum Genet 80:205-220 (2007).
53. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J: Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 16:614-618 (2008).
54. Lee A, Li W, Xu K, Bogert BA, Su K, Gao FB: Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Development 130:5543-5552 (2003).
55. Leyssen M, Hassan BA: A fruitfly's guide to keeping the brain wired. EMBO Rep 8:46-50 (2007).
56. Lipps HJ, Jenke AC, Nehlsen K, Scinteie MF, Stehle IM, Bode J: Chromosome-based vectors for gene therapy. Gene 304:23-33 (2003).
57. Lu X, Shaw CA, Patel A, Li J, Cooper ML, et al: Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS ONE 2:e327 (2007).
58. Lugtenberg D, de Brouwer AP, Kleefstra T, Oudakker AR, Frints SG, et al: Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH. J Med Genet 43:362-370 (2006a).
59. Lugtenberg D, Yntema HG, Banning MJ, Oudakker AR, Firth HV, et al: ZNF674: A new Kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am J Hum Genet 78:265-278 (2006b).
60. Macarov M, Zeigler M, Newman JP, Strich D, Sury V, et al: Deletions of VCX-A and NLGN4 : a variable phenotype including normal intellect. J Intellect Disabil Res 51:329-333 (2007).
61. Madrigal I, Rodriguez-Revenga L, Armengol L, Gonzalez E, Rodriguez B, et al: X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation. BMC Genomics 8:443 (2007a).
62. Madrigal I, Rodriguez-Revenga L, Badenas C, Sanchez A, Martinez F, et al: MLPA as first screening method for the detection of microduplications and microdeletions in patients with X-linked mental retardation. Genet Med 9:117-122 (2007b).
63. Mandel JL, Chelly J: Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations. Eur J Hum Genet 12:689-693 (2004).
64. Marques Pereira P, Heron D, Hanauer A: The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient. Hum Genet 122:541-543 (2007).
65. McBride SM, Choi CH, Wang Y, Liebelt D, Braunstein E, et al: Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45:753-764 (2005).
66. McCarroll SA, Hadnott TN, Perry GH, Sabeti PC, Zody MC, et al: Common deletion polymorphisms in the human genome. Nat Genet 38:86-92 (2006).
67. Meins M, Lehmann J, Gerresheim F, Herchenbach J, Hagedorn M, et al: Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet 42:e12 (2005).
68. Menten B, Maas N, Thienpont B, Buysse K, Vandesompele J, et al: Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 43:625-633 (2006).
69. Michel CI, Kraft R, Restifo LL: Defective neuronal development in the mushroom bodies of Drosophila fragile X mental retardation 1 mutants. J Neurosci 24:5798-5809 (2004).
70. Morales J, Hiesinger PR, Schroeder AJ, Kume K, Verstreken P, et al: Drosophila fragile X protein, DFXR, regulates neuronal morphology and function in the brain. Neuron 34:61-972 (2002).
71. Nielsen DM, Derber WJ, McClellan DA, Crnic LS: Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome. Brain Res 927:8-17 (2002).
72. Patsalis PC, Kousoulidou L, Mannik K, Sismani C, Zilina O, et al: Detection of small genomic imbalances using microarray-based multiplex amplifiable probe hybridization. Eur J Hum Genet 15:162-172 (2007).
73. Piccini M, Vitelli F, Bruttini M, Pober BR, Jonsson JJ, et al: FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics 47:350-358 (1998).
74. Pickering DL, Eudy JD, Olney AH, Dave BJ, Golden D, et al: Array-based comparative genomic hybridization analysis of 1176 consecutive clinical genetics investigations. Genet Med 10:262-266 (2008).
75. Plenge RM, Stevenson RA, Lubs HA, Schwartz CE, Willard HF: Skewed X-chromosome inactivation is a common feature of X-linked mental retardation disorders. Am J Hum Genet 71:168-173 (2002).
76. Raymond FL, Tarpey P: The genetics of mental retardation. Hum Mol Genet 15 Spec No 2:R110-R116 (2006).
77. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444:444-454 (2006).
78. Reeve SP, Bassetto L, Genova GK, Kleyner Y, Leyssen M, et al: The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain. Curr Biol 15:1156-1163 (2005).
79. Restifo LL: Mental retardation genes in Drosophila : New approaches to understanding and treating developmental brain disorders. Ment Retard Dev Disabil Res Rev 11:286-294 (2005).
80. Ropers HH: X-linked mental retardation: many genes for a complex disorder. Curr Opin Genet Dev 16:260-269 (2006).
81. Rosenberg C, Knijnenburg J, Bakker E, Vianna-Morgante AM, Sloos W, et al: Array-CGH detection of micro rearrangements in mentally retarded individuals: clinical significance of imbalances present both in affected children and normal parents. J Med Genet 43:180-186 (2006).
82. Salehi A, Faizit M, Belichenko PV, Mobley WC: Using mouse models to explore genotype-phenotype relationship in Down syndrome. Ment Retard Dev Disabil Res Rev 13:207-214 (2007).
83. Saugier-Veber P, Goldenberg A, Drouin-Garraud V, de La Rochebrochard C, Layet V, et al: Simple detection of genomic microdeletions and microduplications using QMPSF in patients with idiopathic mental retardation. Eur J Hum Genet 14:1009-1017 (2006).
84. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al: Large-scale copy number polymorphism in the human genome. Science 305:525-528 (2004).
85. Shaffer LG, Kashork CD, Saleki R, Rorem E, Sundin K, et al: Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatr 149:8-102 (2006).
86. Shmerling D, Danzer CP, Mao XH, Boisclair J, Haffner M, et al: Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by cre/lox cassette replacement. Genesis 42:229-235 (2005).
87. Smyk M, Obersztyn E, Nowakowska B, Nawara M, Cheung SW, et al: Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am J Med Genet B Neuropsychiatr Genet 147B:799-806 (2008).
88. Suls A, Claeys KG, Goossens D, Harding B, van LR, et al: Microdeletions involving the SCN1A gene may be common in SCN1A -mutation-negative SMEI patients. Hum Mutat 27:14-920 (2006).
89. Thienpont B, De Ravel T, Van Esch H, Van Schoubroeck D, Moerman P, et al: Partial duplications of the ATRX gene cause the ATR-X syndrome. Eur J Hum Genet 15:1094-1097 (2007).
90. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, et al: Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77:442-453 (2005a).
91. Van Esch H, Hollanders K, Badisco L, Melotte C, Van Hummelen P, et al: Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis. Hum Mol Genet 14:1795-1803 (2005b).
92. Van Esch H, Jansen A, Bauters M, Froyen G, Fryns JP: Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes. Am J Med Genet A 143:364-369 (2007).
93. Veltman JA, Yntema HG, Lugtenberg D, Arts H, Briault S, et al: High resolution profiling of X chromosomal aberrations by array comparative genomic hybridisation. J Med Genet 41:425-432 (2004).
94. Voet T, Vermeesch J, Carens A, Durr J, Labaere C, et al: Efficient male and female germline transmission of a human chromosomal vector in mice. Genome Res 11:124-136 (2001).
95. Watase K, Zoghbi HY: Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 4:296-307 (2003).
96. Wu Y, Arai AC, Rumbaugh G, Srivastava AK, Turner G, et al: Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans. Proc Natl Acad Sci USA 104:18163-18168 (2007).
97. Xu K, Bogert BA, Li W, Su K, Lee A, Gao FB: The fragile X-related gene affects the crawling behavior of Drosophila larvae by regulating the mRNA level of the DEG/ENaC protein pickpocket1. Curr Biol 14:1025-1034 (2004).
98. Zarnescu DC, Shan G, Warren ST, Jin P: Come FLY with us: toward understanding fragile X syndrome. Genes Brain Behav 4:385-392 (2005).
99. Zhang YH, Huang BL, Niakan KK, McCabe LL, McCabe ER, Dipple KM: IL1RAPL1 is associated with mental retardation in patients with complex glycerol kinase deficiency who have deletions extending telomeric of DAX1. Hum Mutat 24:273 (2004).
100. Zhang YQ, Bailey AM, Matthies HJ, Renden RB, Smith MA, et al: Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 107:591-603 (2001).